Dacia Dalla Libera

Dacia Dalla Libera

Auto-generated profile, based on publicly available information

Dacia Dalla Libera

Department of Neurology, San Raffaele Hospital, Milan, Italy

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2012 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
CFChiara Fenoglio
Chiara Fenoglio
LMLuca Muzio
Luca Muzio
ETElena Turola
Elena Turola
ABAlessandra Bergami
Alessandra Bergami
LNLuisa Novellino
Luisa Novellino
RFRoberto Furlan
Roberto Furlan

13 December 2013 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PJP Joshi
P Joshi
ETE Turola
E Turola
AMAna Ruiz Moreno
Ana Ruiz Moreno
ABA Bergami
A Bergami
DLD D Libera
D D Libera
CFChiara Fenoglio
Chiara Fenoglio

1 August 2014 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
FAFederica Agosta
Federica Agosta
DLDacia Dalla Libera
Dacia Dalla Libera
ESEdoardo Gioele Spinelli
Edoardo Gioele Spinelli
AFAnnamaria Finardi
Annamaria Finardi
ECElisa Canu
Elisa Canu
RFRoberto Furlan
Roberto Furlan

8 July 2013 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
VMVittorio Martinelli
Vittorio Martinelli
GCGloria Dalla Costa
Gloria Dalla Costa
BCBruno Colombo
Bruno Colombo
DLDacia Dalla Libera
Dacia Dalla Libera
ARAlessandro Rubinacci
Alessandro Rubinacci
GCGiancarlo Comi
Giancarlo Comi
Background: Growing evidence suggests that vitamin D deficiency may be one of the most important environmental factors for the development of multiple sclerosis (MS). Objectives: The objectives of this paper are to evaluate serum 25-hydroxyvitamin D (25(OH)D) levels in patients with clinically isolated syndromes (CIS) and to examine whether they are related to MS risk. Methods: This is a retrospective study of 100 CIS patients hospitalized from 2000 to 2009 at San Raffaele Hospital, Milan, Italy. We evaluated baseline 25(OH)D level as well as clinical, brain magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) data. Results: A total of 52% of CIS patients had vitamin D deficiency (25(OH)D < 50 nmol/l). During follow-up (median: 7.17 years), 55 patients developed clinically definite MS (CDMS). Patients with very low (< 10th percentile) and low (< 25th percentile) 25(OH)D levels were particularly at risk of CDMS (HRs (95% CIs): 2.12 (0.91–4.96) and 1.61 (0.85–3.03), respectively), while no further reduction in the HRs of disease was observed at high levels of 25(OH)D. This association was even stronger after adjustment for additional risk factors for CDMS development (HRs (95% CIs) for 25(OH)D levels < 10th and 25th percentiles: 3.34 (1.32–8.45) and 2.04 (0.96–4.36), respectively). Conclusion: Low serum vitamin D is associated with increased MS risk in patients with CIS.

24 June 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DLDacia Dalla Libera
Dacia Dalla Libera
DMDiletta Di Mitri
Diletta Di Mitri
ABAlessandra Bergami
Alessandra Bergami
Diego CentonzeDiego Centonze
Diego Centonze
CGClaudio Gasperini
Claudio Gasperini
RFRoberto Furlan
Roberto Furlan
FoxP3+ Treg cells are believed to play a role in the occurrence of autoimmunity and in the determination of clinical recurrences. Contradictory reports are, however, available describing frequency and function of Treg cells during autoimmune diseases. We examined, by both polychromatic flow cytometry, and real-time RT-PCR, several Treg markers in peripheral blood mononuclear cells from patients with multiple sclerosis (MS), an autoimmune disease affecting the central nervous system. We found that Tregs, as defined by CD25, CD39, FoxP3, CTLA4, and GITR expression, were significantly decreased in stable MS patients as compared to healthy donors, but, surprisingly, restored to normal levels during an acute clinical attack. We conclude that Treg cells are not involved in causing clinical relapses, but rather react to inflammation in the attempt to restore homeostasis.

1 December 2011 in EPMA Journal
Verified
Journal Article
Open access
PDF file
AMAntonio Morandi
Antonio Morandi
CTCarmen Tosto
Carmen Tosto
PSPaolo Roberti Di Sarsina
Paolo Roberti Di Sarsina
DLDacia Dalla Libera
Dacia Dalla Libera
Ayurveda, the ancient traditional medicine of India, defines health as a state of complete physical, mental and spiritual well-being. The focus of Ayurveda is on a predictive, preventive and personalized medicine. This is obtained through a low-cost personalized counseling about lifestyle measures (diet, activities, etc.), trying to involve the patient directly in the process of healing, increasing his self-awareness and good relationships with other people and nature. The approach of Ayurveda toward positive health shares its features with that of salutogenesis as described by Antonovsky. Prevention strategies pragmatically suggested by Ayurveda - including factors such as promotion of health education, individual awareness, integration of spirituality and ethics in healthcare system- may be applied in public health management, in order to improve perceived and objective life quality, promote healthy aging, limit drugs use (avoiding expensive side-effects) and reduce chronic diseases social costs. Ayurveda has a universal-coverage, being person-centered and consequently intercultural.